Wuxi, Anhui, China The main department of described Corporate Investor is located in the Wuxi. The fund was located in Asia if to be more exact in China.
Among the various public portfolio startups of the fund, we may underline Duoning Biotech, Inhibrx We can highlight the next thriving fund investment areas, such as Health Care, Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - China.
The usual cause for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Viking Global Investors, RA Capital Management, Lilly Asia Ventures.
The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund.
| Fund Name | Location |
| Altmore Capital | Nebraska, United States, Virginia |
| BM H Beteiligungs-Managementgesellschaft Hessen | Germany, Hessen, Wiesbaden |
| BrainLAB | Bayern, Germany, Munich |
| Carlton Communications | England, London, United Kingdom |
| Castle Island Ventures | Cambridge, Massachusetts, United States |
| Chongshan Capital | China, Guangdong, Jiangxi |
| Coeur Mining Inc. | Chicago, Illinois, United States |
| CS Group | - |
| Dimension 6 | - |
| Egis Technology | Taipei, Taiwan |
| Green Shield Canada | Canada, Ontario, Windsor |
| Irontek | Beloit, United States, Wisconsin |
| Juxing Borun Touzi | Chengdu, China, Sichuan |
| Louisiana Technology Innovation Fund | Baton Rouge, Louisiana, United States |
| M. H. Carnegie & Co. | Australia, Paddington, Western Australia |
| MState | New City, New York, United States |
| National Association of College Stores | Oberlin, Ohio, United States |
| Northeast Securities | New York, New York, United States |
| Yadu Corporation | Delhi, India, New Delhi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Innolake Biopharm | $15M | 05 Jun 2023 | Hangzhou, Zhejiang, China | ||
| $90M | 19 May 2021 | Shanghai, China | |||
Innolake Biopharm | $46M | 01 Jan 2021 | Hangzhou, Zhejiang, China | ||
Invetx | $10M | 30 Sep 2020 | Boston, Massachusetts, United States | ||
Invetx | $15M | 24 Feb 2020 | Boston, Massachusetts, United States | ||
Duoning Biotech | $15M | 23 Apr 2019 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Innolake Biopharm | $15M | 05 Jun 2023 | Hangzhou, Zhejiang, China | ||
| $90M | 19 May 2021 | Shanghai, China | |||
Innolake Biopharm | $46M | 01 Jan 2021 | Hangzhou, Zhejiang, China | ||
Invetx | $10M | 30 Sep 2020 | Boston, Massachusetts, United States | ||
Invetx | $15M | 24 Feb 2020 | Boston, Massachusetts, United States | ||
Duoning Biotech | $15M | 23 Apr 2019 | Shanghai, China |
